Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $32.3B |
| FY2017, ended Dec 31, 2017 | $38.2B |
| FY2018, ended Dec 31, 2018 | $25.7B |
| FY2019, ended Dec 31, 2019 | $28.7B |
| FY2020, ended Dec 31, 2020 | $34.2B |
| FY2021, ended Dec 31, 2021 | $39.1B |
| FY2022, ended Dec 31, 2022 | $22.3B |
| FY2023, ended Dec 31, 2023 | $22.6B |
| FY2024, ended Dec 31, 2024 | $28.9B |
| FY2025, ended Dec 31, 2025 | $39.0B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $49.7B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $9.30B |
| FY2017, ended Dec 31, 2017 | $9.93B |
| FY2018, ended Dec 31, 2018 | $8.65B |
| FY2019, ended Dec 31, 2019 | $7.43B |
| FY2020, ended Dec 31, 2020 | $8.89B |
| FY2021, ended Dec 31, 2021 | $10.4B |
| FY2022, ended Dec 31, 2022 | $9.79B |
| FY2023, ended Dec 31, 2023 | $10.1B |
| FY2024, ended Dec 31, 2024 | $10.3B |
| FY2025, ended Dec 31, 2025 | $11.1B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $12.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $7.27B | $2.20B |
| FY2017, ended Dec 31, 2017 | −$1.02B | $2.48B |
| FY2018, ended Dec 31, 2018 | $2.53B | $2.04B |
| FY2019, ended Dec 31, 2019 | $1.79B | $2.61B |
| FY2020, ended Dec 31, 2020 | $5.67B | $1.96B |
| FY2021, ended Dec 31, 2021 | $13.6B | $2.21B |
| FY2022, ended Dec 31, 2022 | −$1.27B | $1.80B |
| FY2023, ended Dec 31, 2023 | $2.77B | $1.97B |
| FY2024, ended Dec 31, 2024 | $1.98B | $1.96B |
| FY2025, ended Dec 31, 2025 | $2.03B | $1.43B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.23B | $2.43B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.82B |
| FY2017, ended Dec 31, 2017 | $2.12B |
| FY2018, ended Dec 31, 2018 | $2.20B |
| FY2019, ended Dec 31, 2019 | $901M |
| FY2020, ended Dec 31, 2020 | $1.10B |
| FY2021, ended Dec 31, 2021 | $1.38B |
| FY2022, ended Dec 31, 2022 | $2.15B |
| FY2023, ended Dec 31, 2023 | $1.99B |
| FY2024, ended Dec 31, 2024 | $2.43B |
| FY2025, ended Dec 31, 2025 | $1.87B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.31B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $8.96B |
| FY2017, ended Dec 31, 2017 | $10.0B |
| FY2018, ended Dec 31, 2018 | $9.23B |
| FY2019, ended Dec 31, 2019 | $7.76B |
| FY2020, ended Dec 31, 2020 | $7.75B |
| FY2021, ended Dec 31, 2021 | $9.08B |
| FY2022, ended Dec 31, 2022 | $8.87B |
| FY2023, ended Dec 31, 2023 | $7.72B |
| FY2024, ended Dec 31, 2024 | $7.42B |
| FY2025, ended Dec 31, 2025 | $6.75B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $6.74B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 59.1% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 1.09B |
| FY2017, ended Dec 31, 2017 | 1.01B |
| FY2018, ended Dec 31, 2018 | 915M |
| FY2019, ended Dec 31, 2019 | 796M |
| FY2020, ended Dec 31, 2020 | 680M |
| FY2021, ended Dec 31, 2021 | 588M |
| FY2022, ended Dec 31, 2022 | 537M |
| FY2023, ended Dec 31, 2023 | 518M |
| FY2024, ended Dec 31, 2024 | 466M |
| FY2025, ended Dec 31, 2025 | 448M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 445M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $2.94B | $416M | $102M |
| FY2017, ended Dec 31, 2017 | $2.75B | $483M | $120M |
| FY2018, ended Dec 31, 2018 | $4.50B | $465M | $109M |
| FY2019, ended Dec 31, 2019 | $4.97B | $415M | $106M |
| FY2020, ended Dec 31, 2020 | $5.14B | $417M | $90.0M |
| FY2021, ended Dec 31, 2021 | $7.05B | $477M | $93.0M |
| FY2022, ended Dec 31, 2022 | $3.14B | $494M | $87.0M |
| FY2023, ended Dec 31, 2023 | $1.40B | $575M | $83.0M |
| FY2024, ended Dec 31, 2024 | $3.15B | $588M | $92.0M |
| FY2025, ended Dec 31, 2025 | $2.50B | $607M | $141M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.07B | $644M | $112M |
Valuation
At current price- Market Cap
- $52.4B
- P/E
- 23.5×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.4×
- Price / Book
- 11.2×
- EV / EBITDA
- 19.2×
Growth
Trailing 12 months- Revenue (TTM)
- $12.0B
- Revenue Growth YoY
- 14.7%
- Revenue CAGR 3Y
- 4.3%
- Revenue CAGR 5Y
- 4.5%
- EPS Growth YoY
- 8.5%
- Net Income Growth YoY
- 2.5%
Profitability
Trailing 12 months- Gross Margin
- 72.1%
- Operating Margin
- 20.6%
- Net Margin
- 18.6%
- FCF Margin
- 20.2%
- Return on Equity
- 48.0%
Earnings
Trailing 12 months- Net Income
- $2.23B
- EPS (diluted)
- $4.85
- EBITDA
- $2.96B
- Operating Income
- $2.47B
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $2.31B
- Total Debt
- $6.74B
- Net Debt
- $4.42B
- Total Assets
- $17.9B
- Total Liabilities
- $13.3B
- Shareholders' Equity
- $4.67B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.04B
- Capital Expenditure
- $608M
- Free Cash Flow
- $2.43B
Dividends and risk
Last 12 months- Dividend Yield
- 1.0%
- Dividend / Share
- $1.22
- Beta (5Y)
- 1.33
Every ratio is calculated from the company’s reported figures.